RVVTF (Revive Therapeutics) FCF Yield % : -86.00 (As of Dec. 13, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Revive Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Revive Therapeutics's Trailing 12-Month Free Cash Flow is $-2.42 Mil, and Market Cap is $1.47 Mil. Therefore, Revive Therapeutics's FCF Yield % for today is -86.00%.

The historical rank and industry rank for Revive Therapeutics's FCF Yield % or its related term are showing as below:

RVVTF' s FCF Yield % Range Over the Past 10 Years
Min: -231.48 Med: 0 Max: 0
Current: -86

RVVTF's FCF Yield % is ranked worse than
94.8% of 1038 companies
in the Drug Manufacturers industry
Industry Median: 0.125 vs RVVTF: -86.00

Revive Therapeutics's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

Revive Therapeutics FCF Yield % Historical Data

The historical data trend for Revive Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revive Therapeutics FCF Yield % Chart

Revive Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

FCF Yield %

Get a 7-Day Free Trial

-4.37

-6.19

-9.07

-33.11

-76.48

Revive Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Yield %	Get a 7-Day Free Trial															-12.93	-33.38	-54.76	-25.61	-52.64

Competitive Comparison of Revive Therapeutics's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Revive Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Revive Therapeutics's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Revive Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Revive Therapeutics's FCF Yield % falls into.

Revive Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Revive Therapeutics's FCF Yield % for the fiscal year that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-2.401	/	3.13923
	=	-76.48%

Revive Therapeutics's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.347	*	4	/	2.6369532
	=	-52.64%

Revive Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Revive Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Revive Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Revive Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (OTCPK:RVVTF) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

31R:Germany RVV:Canada

Address

82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C 1P1

Website

https://www.revivethera.com

Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care. Currently, the Company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics through various program.